P20—Agalsidase Beta Treatment is Associated With...

Clinical Therapeutics 2012 Vol. 34; Iss. 4-supp-S

P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry

U. Feldt-Rasmussen, T. Watt, A.P. Burlina, C. Cazzorla, D. Schönfeld, M. Banikazemi, R.J. Hopkin, A.M. Martins, K. Sims, D. Beitner-Johnson, F. O'Brien
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
34
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.clinthera.2012.03.049
File:
PDF, 54 KB
english, 2012
Conversion to is in progress
Conversion to is failed